Inventor · disambiguated record
Bakulesh Mafatlal Khamar
Also filed as: KHAMAR BAKULESH M · KHAMAR BAKULESH MAFATLAL
19 granted patents·15 pending applications·54 citations·filing 1998–2019
91Inventor score
Files withCADILA PHARMACEUTICALS LTD14KHAMAR BAKULESH MAFATLAL13MODI INDRAVADAN AMBALAL4CADILA PHAMACEUTICALS LTD1KHAMAR BAKULESH M1
Top patents by PatentIndex Score
34 records- 0181US10335472B2Therapeutic cancer vaccineCADILA PHARMACEUTICALS LTD·Filed 2017·Granted Jul 2, 2019·2 cites·7 claims
- 0277US8048434B2Vaccine adjuvantsCADILA PHARMACEUTICALS LTD·Filed 2006·Granted Nov 1, 2011·3 cites·22 claims
- 0375US9029567B2Hypoglycemic compoundsKHAMAR BAKULESH MAFATLAL·Filed 2011·Granted May 12, 2015·2 cites·8 claims
- 0473US8647643B2Farnesoid-X-receptor antagonist as a vaccine adjuvantKHAMAR BAKULESH MAFATLAL·Filed 2009·Granted Feb 11, 2014·1 cites·5 claims
- 0573US7972609B2Method of treating cancerCADILA PHARMACEUTICALS LTD·Filed 2002·Granted Jul 5, 2011·7 cites·29 claims
- 0672US8277778B2Vaccine adjuvantsKHAMAR BAKULESH MAFATLAL·Filed 2011·Granted Oct 2, 2012·2 cites·15 claims
- 0770US9795659B2Pharmaceutical composition of killed cells with substantially retained immunogenicityKHAMAR BAKULESH MAFATLAL·Filed 2011·Granted Oct 24, 2017·2 cites·4 claims
- 0867US11219674B2Therapeutic cancer vaccineCADILA PHARMACEUTICALS LTD·Filed 2019·Granted Jan 11, 2022·0 cites·6 claims
- 0966US9345683B2Pharmaceutical composition of taxoidsKHAMAR BAKULESH MAFATLAL·Filed 2011·Granted May 24, 2016·2 cites·9 claims
- 1062US6306391B1Preparation of an oral pharmaceutical formulation containing an anti-infective agent and a microorganismCADILA PHARMACEUTICALS LTD·Filed 1998·Granted Oct 23, 2001·31 cites·16 claims
- 1158US9789187B2Stable pharmaceutical composition for atherosclerosisKHAMAR BAKULESH MAFATLAL·Filed 2010·Granted Oct 17, 2017·1 cites·11 claims
- 1258US9474727B2Pharmaceutical compositions of curcuminKHAMAR BAKULESH MAFATLAL·Filed 2011·Granted Oct 25, 2016·1 cites·12 claims
- 1358US8563517B2Dipeptidyl peptidase IV (DP-IV) compoundsKHAMAR BAKULESH MAFATLAL·Filed 2009·Granted Oct 22, 2013·0 cites·4 claims
- 1455US2011020440A1Stable solutions of sparingly soluble activesCADILA PHARMACEUTICALS LTD·Filed 2008·Application pending·0 cites
- 1555US2013330375A1Therapeutic Cancer VaccineKHAMAR BAKULESH MAFATLAL·Filed 2012·Application pending·0 cites
- 1653US8110204B2Method of treating human-immunodeficiency virus (HIV) disease infectionKHAMAR BAKULESH MAFATLAL·Filed 2002·Granted Feb 7, 2012·0 cites·29 claims
- 1750US8333978B2Poly TLR antagonistMODI INDRAVADAN AMBALAL·Filed 2007·Granted Dec 18, 2012·0 cites·7 claims
- 1849US2010113802A1Process for preparing amorphous atorvastatin hemi calcium salt and its itermediateCADILA PHARMACEUTICALS LTD·Filed 2007·Application pending·0 cites
- 1949US2010104536A1P38 inhibitorsMODI INDRAVADAN AMBALAL·Filed 2008·Application pending·0 cites
- 2048US2008091022A1Preparation for methscopolamine tannateCADILA PHAMACEUTICALS LTD·Filed 2007·Application pending·0 cites
- 2147US9415078B2Method of treating desmocollin-3 expressing cancer with Mycobacterium wCADILA PHARMACEUTICALS LTD·Filed 2015·Granted Aug 16, 2016·0 cites·7 claims
- 2247US2009137633A1Stable pharmaceutical composition of rabeprazoleKHAMAR BAKULESH MAFATLAL·Filed 2004·Application pending·0 cites
- 2347US2010209394A1Mitogen activated protein kinase modulatorCADILA PHARMACEUTICALS LTD·Filed 2008·Application pending·0 cites
- 2446US2013295648A1Pharmaceutical composition for treating cancerKHAMAR BAKULESH MAFATLAL·Filed 2012·Application pending·0 cites
- 2545US10882819B2Synthesis of novel intermediate(s) for preparing rivastigmineCADILA PHARMACEUTICALS LTD·Filed 2019·Granted Jan 5, 2021·0 cites·8 claims
- 2644US8153102B2Process for manufacturing pharmaceutical composition comprises of Mycobacterium w in the treatment of asthma (obstructive lung disease)MODI RAJIV INDRAVADAN·Filed 2003·Granted Apr 10, 2012·0 cites·21 claims
- 2744US2014045771A1Novel dipeptidyl peptidase iv (dp-iv) compoundsCADILA PHARMACEUTICALS LTD·Filed 2013·Application pending·0 cites
- 2842US2002025309A1Stable oral pharmaceutical formulation containing an anti-infective agent and a microorganismCADILA PHARMACEUTICALS LTD·Filed 2001·Application pending·0 cites
- 2941US2012328574A1P38 inhibitorsMODI INDRAVADAN AMBALAL·Filed 2012·Application pending·0 cites
- 3040US2009177008A1Novel process for synthesis of itopride and its novel intermediate n-(4-hydroxybenzyl)- 3,4-dimethoxybenzamideCADILA PHARMACEUTICALS LTD·Filed 2006·Application pending·0 cites
- 3138US2018042850A1Pharmaceutical Composition of Killed Cells with Substantially Retained ImmunogenicityCADILA PHARMACEUTICALS LTD·Filed 2017·Application pending·0 cites
- 3236US2007249839A1Process for the Preparation of Losartan Potassium Form IKHAMAR BAKULESH M·Filed 2006·Application pending·0 cites
- 3335US2013137852A1Novel compounds as dpp-iv inhibitors and process for preparation thereofKHAMAR BAKULESH MAFATLAL·Filed 2011·Application pending·0 cites
- 3434US9714275B2Cancer antigenMODI INDRAVADAN AMBALAL·Filed 2012·Granted Jul 25, 2017·0 cites·6 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →